EVALUATION OF HEPATECTOMY FOR HEPATIC METASTASES OF COLORECTAL CANCER

Bibliographic Information

Other Title
  • 肝切除を施行した大腸癌肝転移症例の検討

Search this article

Abstract

Twenty-eight patients received a hepatectomy for hepatic metastases of colorectal cancer at the department from April 1984 to December 1993 were evaluated, especially for H1 patients. We prefered hepatectomy with a surgical margin of more than 1cm. In addition, the continuous infusion therapy with 5-FU (250mg/day) into the hepatic artery was selected as a postoperative adjuvant therapy. Three-year and five-year survivals with H1 patients resulted in 45% and 28%, respectively. None of H2 patients survived more than three years. Recurrence was noted in 43% of H1 patients, and about 90% of the recurrences occurred in the remnant liver after hepatic resection. There was no significant difference between synchronous and metachronous metastases or between males and females. The patients underwent accurate segmentectomy got a favorable prognosis compared with partial hepatectomy. The five-year survival rate of patients undergoing hepatectomy added postoperative chemotherapy combined with continuous hepatic arterial infusion, was 33% which was favorable compared with those added chemotherapy only, without significant.<br> We think that aggressive large resection of the liver including metastatic tumor combined with postoperative chemotherapy using hepatic arterial infusion is an effective treatment of hepatic metastases of colorectal cance for prognostic improvement.

Journal

Citations (4)*help

See more

References(13)*help

See more

Details 詳細情報について

Report a problem

Back to top